Apr 17, 2026 06:48AM H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)

Apr 16, 2026 03:17PM Jefferies on Aligos Therapeutics Inc. (ALGS): 'looks cheap' ahead of Ph2 data

Apr 16, 2026 06:02AM Aligos licenses hepatitis B drug to Amoytop for $25M upfront

Mar 26, 2026 09:03AM WestPark Capital Starts Aligos Therapeutics Inc. (ALGS) at Buy

Mar 19, 2026 02:34AM Jefferies Assumes Aligos Therapeutics Inc. (ALGS) at Buy

Mar 5, 2026 04:02PM Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c

Jan 23, 2026 06:52AM H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)

Jan 7, 2026 12:38AM UBS Starts Aligos Therapeutics Inc. (ALGS) at Buy

Dec 11, 2025 08:04AM Aligos presents drug combination data at hepatitis conference

Oct 16, 2025 08:34AM Aligos gets USAN approval for pevifoscorvir sodium drug name

Sep 19, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)

Aug 20, 2025 08:31AM Aligos appoints Ramón Polo as head of global regulatory affairs

Aug 18, 2025 06:39AM H.C. Wainwright Assumes Aligos Therapeutics Inc. (ALGS) at Buy

Aug 6, 2025 06:26PM Aligos Therapeutics Inc. (ALGS) Misses Q2 EPS by 153c

May 8, 2025 08:06AM Aligos Therapeutics (ALGS) Presents Positive Data at the EASL Congress 2025

Mar 27, 2025 04:12PM Aligos Therapeutics Inc. (ALGS) Files for 6.25M Share Offering by Selling Stockholders

Mar 12, 2025 06:41AM Aligos Therapeutics Inc. (ALGS) PT Lowered to $70 at H.C. Wainwright

Mar 10, 2025 04:27PM Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 1308c

Feb 12, 2025 07:00AM Aligos Therapeutics Inc. (ALGS) Announces $105M Private Placement

Nov 19, 2024 01:31PM Aligos Therapeutics (ALGS) Presents Positive Data at The Liver Meeting

Nov 6, 2024 05:10PM Aligos Therapeutics, Inc. (ALGS) Misses Q3 EPS by 290c

Oct 1, 2024 08:02AM Aligos Therapeutics Inc. (ALGS) Appoints David Perry as Vice President of Business Development

Sep 24, 2024 08:02AM Aligos Therapeutics (ALGS) Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

Sep 24, 2024 07:52AM Piper Sandler Reiterates Overweight Rating on Aligos Therapeutics Inc. (ALGS)

Sep 20, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)

Sep 19, 2024 08:00AM Aligos Therapeutics Inc. (ALGS) Announces Positive Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH

Sep 18, 2024 05:02PM Aligos Therapeutics Inc. (ALGS) to Report Data from Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024

Sep 12, 2024 07:40AM Piper Sandler Reiterates Overweight Rating on Aligos Therapeutics Inc. (ALGS)

Aug 19, 2024 06:13AM H.C. Wainwright Starts Aligos Therapeutics Inc. (ALGS) at Buy

Aug 6, 2024 05:05PM Aligos Therapeutics, Inc. (ALGS) Tops Q2 EPS by 19c

Jul 19, 2024 02:34PM Piper Sandler Reiterates Overweight Rating on Aligos Therapeutics Inc. (ALGS)